Two PhD Graduate Students Celebrate Completing the Program
On April 17, 2025, Duke’s Graduate Program in Pathobiology and Translational Biosciences
How a Little-Known Protein Powers Energy Production and Fights Cancer
The Nature Cell Biology study led by Duke Pathology’s Hui-Kuan Lin, PhD, reshapes what scientists know about how our cells create energy and ward off cancer.
Dr. Carolyn Glass Receives the 2025 Margaret Billingham Award
Duke Division Chief of Cardiovascular Pathology Carolyn Glass, MD, PhD, received the 2024-20
Dr. Thomas J. Cummings Hosts AAPath Conference for New Program Directors
On May 1, 2025, Professor of Pathology and Residency Program Director
Dr. Elizabeth Pavlisko Presents About Lung Transplant Recipients’ Risk for CLAD
Professor Elizabeth Pavlisko, MD, lectured on tissue and biopsy hallmarks of chronic lung allograft dysfunction (CLAD) at the annual
Dr. Diana Kozman Presents on Endometrial Cancer Classification at NCSP Annual Meeting
On May 3, 2025, Diana Kozman, MD, presented "E
A New Treatment Strategy for Synovial Sarcoma
Synovial sarcoma is a rare, aggressive soft tissue cancer with few effective treatment options. Duke researchers, including Pathology’s Dr. Ling Cai, have found a weakness in the disease, suggesting a possible new treatment.
Dr. Thomas J. Cummings Lectures on the Pathology of Drug-Related Corneal Deposits at VZS Meeting
Professor of Pathology and Residency Program Director
Scientists Hack Cell Entry to Supercharge Cancer Drugs
Work by Duke University School of Medicine cancer researcher and pathology professor Dr. Hui-Kuan Lin could help revive drugs once considered too big to work.